Blood Research

Cited by CrossRef (19)

  1. Chantana Polprasert, Kitsada Wudhikarn, Ponlapat Rojnuckarin. Immune dysregulation in extranodal NK/T cell lymphomas: potential roles in pathogenesis and immunotherapy. Blood Res 2021;56:209
    https://doi.org/10.5045/br.2021.2021123
  2. Lei Zhang, Chenxing Shangguan, Xin Li, Ling Li, Xinhua Wang, Xiaorui Fu, Zhenchang Sun, Yonggang Shi, Jingjing Wu, Xudong Zhang, Hui Yu, Feifei Nan, Jiaqin Yan, Yu Chang, Zhiyuan Zhou, Xiaolong Wu, Xiaoyan Feng, Xiyang Liu, Hongwei Xue, Liqun Zou, Yi Lu, Jinghua Wang, Guannan Wang, Wencai Li, Mingzhi Zhang. DDGP followed by radiotherapy vs VIPD followed by radiotherapy in newly diagnosed early NK/T-cell lymphoma. Leukemia Research 2022;118:106881
    https://doi.org/10.1016/j.leukres.2022.106881
  3. Xiao-Peng Tian, Jun Cai, Yi Xia, Yu-Chen Zhang, Liang Wang, Pan-Pan Liu, Hui-Qiang Huang, Ya-Jun Li, Hui Zhou, Zhi-Ming Li, Jing Yang, Li-Qiang Wei, Qi-Hua Zou, Ying Huang, Jun Li, Li Ling, Wen-Long Zhong, Qing-Qing Cai. First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial. The Lancet Haematology 2024
    https://doi.org/10.1016/S2352-3026(24)00066-8
  4. Jun Seop Kim, Tae Hoon An, Nam-Kyung Yeo. A Case of Extranodal Natural Killer/T Cell Lymphoma Combined With Actinomycosis. Korean J Otorhinolaryngol-Head Neck Surg 2022;65:727
    https://doi.org/10.3342/kjorl-hns.2022.00703
  5. Xiaohua He, Yan Gao, Zhiming Li, Huiqiang Huang. Review on natural killer/T‐cell lymphoma. Hematological Oncology 2023;41:221
    https://doi.org/10.1002/hon.2944
  6. Jasmine M. Zain, Paul Hanona. Aggressive T‐cell lymphomas: 2021 Updates on diagnosis, risk stratification and management. American J Hematol 2021;96:1027
    https://doi.org/10.1002/ajh.26270
  7. Xiao-Peng Tian, Shu-Yun Ma, Ken H. Young, Choon Kiat Ong, Yan-Hui Liu, Zhi-Hua Li, Qiong-Li Zhai, Hui-Qiang Huang, Tong-Yu Lin, Zhi-Ming Li, Zhong-Jun Xia, Li-Ye Zhong, Hui-Lan Rao, Mei Li, Jun Cai, Yu-Chen Zhang, Fen Zhang, Ning Su, Peng-Fei Li, Feng Zhu, Zijun Y. Xu-Monette, Esther Kam Yin Wong, Jeslin Chian Hung Ha, Lay Poh Khoo, Le Ai, Run-Fen Cheng, Jing Quan Lim, Sanjay de Mel, Siok-Bian Ng, Soon Thye Lim, Qing-Qing Cai. A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma. 2021;138:452
    https://doi.org/10.1182/blood.2020010637
  8. Jing Tian, Miaowang Hao, Qiang Liu, Fang Xiao, Yuanchun Li, Meiying Qi, Jing Gao, Li Liu, Dandan Yin. Efficacy and safety of PD‐1 inhibitor alone or combined with chemotherapy in patients with relapsed or refractory extranodal natural Killer/T cell lymphoma: A retrospective study. Hematological Oncology 2023;41:396
    https://doi.org/10.1002/hon.3116
  9. Yue Chai, Bo Chen, Fei Qi, Hui Fang, Shu-Nan Qi, Ru-Yuan Guo, Ning Li, Yong Yang, Shu-Lian Wang, Yong-Wen Song, Jian-Liang Yang, Di Zhang, Yu-Ce Wei, Ye-Xiong Li, Mei Dong. First-Line Chemoradiation With or Without Chidamide (Tucidinostat) in Patients With Intermediate- and High-Risk Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma: A Randomized Phase 2 Study in China. International Journal of Radiation Oncology*Biology*Physics 2022;113:833
    https://doi.org/10.1016/j.ijrobp.2022.04.001
  10. Chuanxu Liu, Xinyu Ding, Gaoyang Li, Youping Zhang, Yubao Shao, Linyi Liu, Wenhao Zhang, Yujie Ma, Wenbin Guan, Lifeng Wang, Zhongli Xu, YungTing Chang, Yongqiang Zhang, Biao Jiang, Qianqian Yin, Rong Tao. Targeting Bcl-xL is a potential therapeutic strategy for extranodal NK/T cell lymphoma. iScience 2023;26:107369
    https://doi.org/10.1016/j.isci.2023.107369
  11. Yadira Noemí Chávez Dávila, Víctor Hugo Pinos León, Sonia Tello Astudillo, Grace Margreth Loza Erazo, Jennyfer Daniela Granizo Rubio. Extranodal NK/T-Cell Lymphoma, Nasal Type, Extranasal and Ulcerative Blister Variant, Case Report. Ann Dermatol 2023;35:S304
    https://doi.org/10.5021/ad.21.317
  12. Eun Kyung Kim, Mi Jang, Woo Ick Yang, Sun Och Yoon. Primary Gastrointestinal T/NK Cell Lymphoma. Cancers 2021;13:2679
    https://doi.org/10.3390/cancers13112679
  13. John C. Reneau, Polina Shindiapina, Zachary Braunstein, Youssef Youssef, Miguel Ruiz, Saira Farid, Walter Hanel, Jonathan E. Brammer. Extranodal Natural Killer/T-Cell Lymphomas: Current Approaches and Future Directions. JCM 2022;11:2699
    https://doi.org/10.3390/jcm11102699
  14. Yang Chunli, Jiang Ming, Ma Ziyan, Ji Jie, Lv Shuli, Huang Jie, Wu Yu, Xu Caigang, Zou Liqun. Real‐World clinical features and survival outcomes associated with primary gastrointestinal natural killer/T‐cell lymphoma from 1999 to 2020. Cancer Medicine 2023;12:2614
    https://doi.org/10.1002/cam4.5136
  15. Yang Wang, Huaicheng Tan, Ting Yu, Xuelei Ma, Xiaoxuan Chen, Fangqi Jing, Liqun Zou, Huashan Shi. The identification of gene signatures in patients with extranodal NK/T-cell lymphoma from a pair of twins. BMC Cancer 2021;21
    https://doi.org/10.1186/s12885-021-09023-9
  16. Cen Qiu, Guangye Du. Loss of LEF‐1 expression as a diagnostic indicator for extranodal NK/T‐cell lymphoma: An immunohistochemical study of 88 cases. European J of Haematology 2022;109:513
    https://doi.org/10.1111/ejh.13836
  17. Rui Lin, Xiaoli Li, Shaoxuan Wu, Siyu Qian, Huting Hou, Meng Dong, Xudong Zhang, Mingzhi Zhang. Suppression of latent transforming growth factor-β (TGF-β)-binding protein 1 (LTBP1) inhibits natural killer/ T cell lymphoma progression by inactivating the TGF-β/Smad and p38MAPK pathways. Experimental Cell Research 2021;407:112790
    https://doi.org/10.1016/j.yexcr.2021.112790
  18. Luping Wang, Mei Jia, Ruxiang Zhang, Giuseppe Casalino, Usha Chakravarthy, Yanling Wang. Bilateral intraocular and lung involvements associated with Nasal NK/T-cell lymphoma. European Journal of Ophthalmology 2023;33:NP97
    https://doi.org/10.1177/11206721211070930
  19. Xiaolan Zhang, Ze Wu, Song Zheng. Erythematous Patch and Ulcerations on the Right Leg: Challenge. 2023;45:431
    https://doi.org/10.1097/DAD.0000000000002431
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd